Financial comparisons IDEXX Laboratories, Inc.
Stocks
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
16:00:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 550.96 USD | -2.82% |
|
-6.09% | -18.56% |
| 08-11 | IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment | MT |
| 08-11 | Idexx Laboratories Launches Catalyst Probnp Test for Cardiac Assessment in Cats and Dogs | CI |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 4.3B | 24.62% | 31.6% | 66.2% | 31.89% | 0.44x | |
| Average | 4.3B | 24.62% | 31.6% | 66.2% | 31.89% | 0.44x | |
| Weighted average by Cap. | 4.3B | 24.62% | 31.6% | 66.2% | 31.89% | 0.44x |
- Stock Market
- Stocks
- IDXX Stock
- Sector IDEXX Laboratories, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
